A few things I gleaned from listening to the Q & A in the CureSHANK webinar this morning:
- The dose used in the trial (which is the same dose that will be used going forward) represents, for a 25kg patient, the equivalent of 5cc (1 teaspoon), taken twice daily.
- While an open label trial design was used in the Phase 2 study, it is expected that Phase 3 will be placebo-controlled.
- Safety was the broad reason for the exclusion of 5 patients after screening.
- Participants in the Phase 3 trial will be excluded from the pivotal Phase 3 trial as neither they nor their parents will be treatment- naïve. However, it is hoped that they can be included in the Phase 3 open label extension component of the trial.
- While not yet decided, it is probable that the pivotal trial will be restricted to the same age group as the Phase 2 trial (3-12 years). However, the company remains committed to extending treatment to all age groups and an additional trial in adolescents is a possibility.
- Geography for the trial is still to be determined.
- The last question was whether it was possible that NNZ-2591 might be applicable to syndromes other than PMS. The founder of CureSHANK was thrilled to hear that NNZ-2591 was being tested in other indications as well and might potentially be a therapeutic used across multiple neurodevelopmental rare diseases.
- Forums
- ASX - By Stock
- NEU
- Ann: 2023 Results webinar
Ann: 2023 Results webinar, page-125
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$21.02 |
Change
0.570(2.79%) |
Mkt cap ! $2.709B |
Open | High | Low | Value | Volume |
$20.56 | $21.55 | $20.54 | $9.282M | 438.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 133 | $21.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.03 | 147 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 134 | 21.000 |
7 | 208 | 20.990 |
12 | 440 | 20.980 |
6 | 401 | 20.970 |
5 | 312 | 20.960 |
Price($) | Vol. | No. |
---|---|---|
21.010 | 32 | 3 |
21.020 | 286 | 5 |
21.030 | 582 | 5 |
21.040 | 816 | 8 |
21.050 | 2523 | 5 |
Last trade - 14.54pm 16/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |